Vernalis Stock Price (OTCMKTS:VNLPY)

Add to My Stocks
$0.58 $0 (0%) VNLPY stock closing price Jul 26, 2017 (Closing)
Prev Close* : $0.58
Market Cap:
$152.67M
Day Low: $0
52 Week Low: $0.47
Open: $0
Volume: 0
Day High: $0
52 Week High: $1.09
Dividend:
N/A

Latest Stock Market News

Latest Articles

VNLPY Stockcharts

View VNLPY PE ratio, PS ratio stocks charts and compare with peers.
VNLPY Chart
Note: Compare Vernalis stock price history with the index and industry peers.

VNLPY Industry Peers

Company Price Change (%)
Madrigal Pharma (MDGL)15.750.05 (0.32%)
Steadymed (STDY)6.750 (0%)
Cti Biopharma (CTIC)3.420.04 (1.18%)
H. Lundbeck (HLUYY)61.722.08 (3.49%)
Biotie Therapies (BITI)25.80.71 (2.68%)
Astrazeneca (AZN)33.940.16 (0.47%)
Glaxosmithkline (GSK)40.851.11 (2.65%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Arrowhead Pharma (ARWR)1.880.28 (17.5%)
Tetraphase Pharmaceuticals (TTPH)7.880.98 (14.2%)
Catalyst Pharma (CPRX)3.140.1 (3.29%)
Genocea Biosciences (GNCA)6.170.17 (2.83%)
GlycoMimetics (GLYC)11.970.31 (2.66%)
Shire (SHPG)169.83.69 (2.22%)
MEI Pharma (MEIP)3.050.06 (2.01%)
Top gainers from Medical-Drugs industry
* As of Jul 27, 2017
CompanyPriceChange (%)
USANA Health Sciences (USNA)57.457.3 (11.27%)
Adamis Pharma (ADMP)4.60.15 (3.16%)
AcelRx Pharma (ACRX)3.70.1 (2.63%)
Concert Pharma (CNCE)15.50.39 (2.45%)
Pacira Pharma (PCRX)41.6251.03 (2.42%)
Cardiome Pharma (CRME)4.530.11 (2.37%)
Aerie Pharma (AERI)54.71.25 (2.23%)
Top losers from Medical-Drugs industry
* As of Jul 27, 2017

Vernalis Financial Statements

income statement20162013201220112010
Net Sales Or Revenues17.85M22.04M23.16M19.5M21.95M
Net Income-21.5M-6.26M-8.31M-12.31M-30.39M
Total Operating Expense49.86M27.43M28.88M33.49M39.86M
view Vernalis plc (ADR) income statement
balance sheet20162014201320122011
Total Assets166.92M145.9M152.08M154.24M58.63M
Total Liabilities14.48M14.55M13.83M16.28M18.82M
Shareholders Equity152.44M131.35M138.25M137.95M39.81M
view Vernalis plc (ADR) balance sheet
cash flow statement2016
Net Increase (Decrease) In Assets Liabilities3.53M
Net Cash From (Used By) Operating Activities-30.82M
Increase (Decrease) In Prop Plant And Equipment-0.31M
view Vernalis plc (ADR) cashflow statement

Vernalis Stock Message Board

An investor needs to spend 0.58 to buy VNLPY stock, as the closing Vernalis stock price is 0.58. Looking at Vernalis market capitalization, which currently stands at 152.67M, we can say that VNLPY stock is a Micro cap stock. Vernalis valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Vernalis stock price and Vernalis share price mean the same thing. 0 shares were traded with a closing stock price of 0.58 as of 26 Jul, 2017, as can be seen from Vernalis stock quote. One can view Vernalis stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of VNLPY, view Vernalis stock price history.